Get the Stockscreener App
6.99
4.90%
-0.36
After Hours:
7.12
0.13
+1.86%
Journey Medical Corp Stock (DERM) Forecast
The Journey Medical Corp (DERM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3633, representing a -80.50% decrease from the current price of $6.99. The highest analyst price target is $1.2277, and the lowest is $1.4989.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DERM Price Target
Average 1.6295
(-76.69% Downside)
Is Journey Medical Corp (DERM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.47 | Neutral |
| STOCH(9,6) | 47.02 | Neutral |
| STOCHRSI(14) | 23.49 | Neutral |
| MACD(12,26) | 0.0915 | Sell |
| ADX(14) | 20.94 | Neutral |
| William %R | -87.29 | Buy |
| CCI(14) | -105.53 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.431
Sell
|
7.3668
Sell
|
| MA20 |
7.2965
Sell
|
7.305
Sell
|
| MA50 |
7.189
Sell
|
7.1172
Sell
|
| MA100 |
6.8137
Buy
|
6.745
Buy
|
| MA200 |
5.9257
Buy
|
6.1551
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, DERM could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on DERM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.47 indicates that DERM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 47.02 indicates that DERM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.49 indicates that DERM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.94 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -105.53 indicates that DERM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term DERM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Journey Medical Corp financial reports and earnings history, Journey Medical Corp (DERM) stock could reach $7.7039 by 2030, $18.40 by 2040 and $41.49 by 2050. See the projected annual prices until 2050 of the Journey Medical Corp stock below:
- Journey Medical Corp (DERM) is expected to reach an average price of $6.1111 in 2035, with a high prediction of $7.3034 and a low estimate of $6.4511. This indicates an $-12.57% rise from the last recorded price of $6.99.
- Journey Medical Corp (DERM) stock is projected to chart a bullish course in 2040, with an average price target of $18.02, representing an $157.73% surge from its current level. The forecast ranges from a conservative $18.23 to a sky-high $18.40.
- Our analysts predict Journey Medical Corp (DERM) to jump 317.79% by 2045, soaring from $29.10 to an average price of $29.20, potentially reaching $28.94. While $29.10 is the low estimate, the potential upside is significant.
- Journey Medical Corp (DERM) stock is expected to climb by 2050, reaching an average of $42.09, a $502.21% jump from its current level. However, a wide range of estimates exists, with high and low targets of $41.49 and $41.60, respectively, highlighting the market's uncertainty.
Journey Medical Corp Stock (DERM) Year by Year Forecast
Journey Medical Corp Stock (DERM) Price Forecast for 2025
Journey Medical Corp Stock (DERM) is expected to reach an average price of $1.3644 in 2025, with a high prediction of $2.2733 and a low estimate of $0.4555. This indicates an -80.48% fall from the last recorded price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $1.0992 | $1.4989 | $1.2277 | -84.27% |
| October, 2025 | $1.8699 | $1.6095 | $1.6835 | -73.25% |
| November, 2025 | $1.8004 | $2.03 | $1.8004 | -74.24% |
| December, 2025 | $1.7211 | $1.7709 | $1.6807 | -75.38% |
Journey Medical Corp Stock (DERM) Price Forecast for 2026
The predicted value for Journey Medical Corp (DERM) in 2026 is set at an average of $2.8492. Estimates vary from a peak of $5.5941 to a trough of $0.1044, indicating an -59.24% surge from the present price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.9966 | $1.8109 | $1.8317 | -71.44% |
| February, 2026 | $1.2921 | $1.4521 | $1.9017 | -81.52% |
| March, 2026 | $1.2126 | $1.2826 | $1.1526 | -82.65% |
| April, 2026 | $0.8532 | $0.9332 | $1.1527 | -87.79% |
| May, 2026 | $0.0963 | $0.8253 | $0.7783 | -98.62% |
| June, 2026 | $0.1158 | $0.2241 | $0.3359 | -98.34% |
| July, 2026 | $0.7751 | $0.1044 | $0.9451 | -88.91% |
| August, 2026 | $1.6746 | $0.5208 | $3.1546 | -76.04% |
| September, 2026 | $3.264 | $1.4976 | $5.5941 | -53.31% |
| October, 2026 | $2.6234 | $2.1639 | $3.675 | -62.47% |
| November, 2026 | $1.9229 | $1.6632 | $2.8133 | -72.49% |
| December, 2026 | $1.1623 | $0.9863 | $2.0424 | -83.37% |
Journey Medical Corp Stock (DERM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Journey Medical Corp (DERM) is $2.8855, with a high forecast of $5.119 and a low forecast of $0.652. This indicates an -58.72% decrease from the last price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2618 | $0.652 | $2.4776 | -67.64% |
| February, 2027 | $1.709 | $1.1664 | $2.2516 | -75.55% |
| March, 2027 | $2.821 | $1.76 | $2.3733 | -59.64% |
| April, 2027 | $4.5321 | $4.1404 | $4.2718 | -35.16% |
| May, 2027 | $3.9431 | $4.3331 | $4.3184 | -43.59% |
| June, 2027 | $4.7644 | $4.3041 | $4.1891 | -31.84% |
| July, 2027 | $4.2954 | $4.5084 | $4.3649 | -38.55% |
| August, 2027 | $4.6264 | $4.3062 | $4.1656 | -33.81% |
| September, 2027 | $4.8177 | $5.1276 | $4.7769 | -31.08% |
| October, 2027 | $5.6887 | $5.0082 | $4.9469 | -18.62% |
| November, 2027 | $4.9598 | $5.1295 | $5.119 | -29.04% |
| December, 2027 | $4.391 | $4.581 | $4.76 | -37.18% |
Journey Medical Corp Stock (DERM) Price Forecast for 2028
In 2028, Journey Medical Corp (DERM) is projected to reach an average price of $5.2629, with a high projection of $5.9617 and a low estimate of $4.5641. This indicates an -24.71% fall from the last price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.0621 | $4.8313 | $4.6868 | -27.58% |
| February, 2028 | $5.4731 | $5.1826 | $5.1431 | -21.70% |
| March, 2028 | $5.4844 | $5.4039 | $5.2656 | -21.54% |
| April, 2028 | $5.8354 | $5.6548 | $5.7454 | -16.52% |
| May, 2028 | $6.1967 | $5.6759 | $5.9617 | -11.35% |
| June, 2028 | $4.8977 | $5.1077 | $5.4113 | -29.93% |
| July, 2028 | $4.9587 | $5.0485 | $4.7968 | -29.06% |
| August, 2028 | $5.41 | $5.119 | $5.1334 | -22.60% |
| September, 2028 | $5.2011 | $5.3011 | $5.1708 | -25.59% |
| October, 2028 | $4.9922 | $5.0618 | $5.0113 | -28.58% |
| November, 2028 | $5.0934 | $5.062 | $5.0734 | -27.13% |
| December, 2028 | $4.5944 | $4.5641 | $4.3437 | -34.27% |
Journey Medical Corp Stock (DERM) Price Forecast for 2029
The 2029 price forecast for Journey Medical Corp Stock (DERM) is $2.8667 on average, with a high prediction of $5.70 and a low estimate of $0.0334. This represents an -58.99% decrease from the previous price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0557 | $4.1957 | $4.1852 | -41.98% |
| February, 2029 | $3.7667 | $3.8664 | $3.7859 | -46.11% |
| March, 2029 | $3.0077 | $3.2827 | $3.5872 | -56.97% |
| April, 2029 | $2.5188 | $2.8588 | $2.5281 | -63.97% |
| May, 2029 | $1.58 | $1.9498 | $2.219 | -77.40% |
| June, 2029 | $0.7511 | $1.078 | $1.0731 | -89.26% |
| July, 2029 | $0.7679 | $0.3979 | $3.0782 | -89.01% |
| August, 2029 | $0.0566 | $0.0334 | $1.1989 | -99.19% |
| September, 2029 | $0.9844 | $0.4741 | $0.4344 | -85.92% |
| October, 2029 | $1.1357 | $0.6949 | $0.7554 | -83.75% |
| November, 2029 | $0.7967 | $0.7165 | $0.3193 | -88.60% |
| December, 2029 | $6.45 | $0.7858 | $5.70 | -7.73% |
Journey Medical Corp Stock (DERM) Price Forecast for 2030
Journey Medical Corp Stock (DERM) is expected to reach an average price of $8.2419 in 2030, with a high forecast of $9.4035 and a low forecast of $7.0804. This signifies an +17.91% surge from the last price of $6.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.9419 | $7.0804 | $7.7039 | +27.92% |
| February, 2030 | $9.3835 | $9.4623 | $9.1127 | +34.24% |
| March, 2030 | $8.935 | $9.0746 | $9.0997 | +27.83% |
| April, 2030 | $9.4065 | $8.9662 | $8.8512 | +34.57% |
| May, 2030 | $8.7785 | $8.9085 | $8.9673 | +25.59% |
| June, 2030 | $9.54 | $8.8092 | $8.7792 | +36.48% |
| July, 2030 | $9.2219 | $9.4619 | $9.2204 | +31.93% |
| August, 2030 | $9.7235 | $9.3523 | $9.4035 | +39.11% |
| September, 2030 | $9.145 | $9.305 | $9.0539 | +30.83% |
| October, 2030 | $8.9369 | $8.7066 | $8.9254 | +27.85% |
| November, 2030 | $8.8885 | $9.2073 | $8.7527 | +27.16% |
| December, 2030 | $9.47 | $9.1693 | $9.16 | +35.48% |
0.87%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):